19 completed, 2 unknown, 2 withdrawn, 1 not yet recruiting. 25 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 25 | Completed 19, Unknown 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1 |
Follow Behavior Therapy: new trials by email Literature Review of Behavior Therapy trials Research Report on Behavior Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1s in Hip and Knee Arthroplasty GLP-1 Receptor Agonists + Behavioral modification, Behavioral + placebo - Arthritis, Obesity & Overweight | Phase 4 | Not yet recruiting | Nova Scotia Health Authority | 100 | 2026-10-01 | 2026-08-10 |
| The Use of Cyproheptadine in Pediatric Feeding Disorders Cyproheptadine, Nutritional Counseling, Behavioral Counseling - Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder | Phase 4 | Completed | University of Miami | 18 | 2024-12-30 | 2026-06-04 |
| A Randomized Controlled Trial of Vitamin D Supplementation on Salivary Biomarkers and Cariogenic Oral Microbiome Vitamin D supplements along with behavioral modification, Topical fluoride application and Vitamin D supplements along with behavioral modification, Topical fluoride application along with behavioral modification - Dental Caries, White Spot Lesion | Phase 4 | Recruiting | Dow University of Health Sciences | 90 | 2023-12-12 | 2025-03-11 |
| Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects Behavioral Treatment, Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY] - Obesity | Phase 4 | Completed | University of Pennsylvania | 120 | 2022-07-26 | 2026-08-03 |
| Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment Behavioral Treatment, Placebo, Phentermine 15 MG - Obesity | Phase 4 | Completed | University of Pennsylvania | 147 | 2019-07-15 | 2025-03-11 |
| Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation Varinecline (Chantix), Placebo (for Varenicline), Behavioral Therapy - Nicotine Dependence | Phase 4 | Completed | American University of Beirut Medical Center | 152 | 2016-08-31 | 2021-03-17 |
| Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes Exenatide-LAR plus Dapagliflozin placebo, Exenatide-LAR plus Dapagliflozin, Insulin Titration - Diabetes Mellitus, Type 2 | Phase 4 | Withdrawn | Weill Medical College of Cornell University | 2016-06-01 | 2017-03-03 | |
| A New Check-list Method for Nocturnal Enuresis desmopressin melt form 120 μg, Verbal behavioral therapy, Behavioral therapy with written check-list - Nocturnal Enuresis | Phase 4 | Completed | Ankara Training and Research Hospital | 75 | 2015-01-01 | 2018-05-01 |
| Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Behavioral Counseling, bupropion-SR - Sleep Disturbance, Fatigue | Phase 4 | Completed | Eva Szigethy | 99 | 2013-07-01 | 2017-09-13 |
| Smoking Cessation Intervention in Respiratory Inpatients Varenicline, Behavioral support - Pulmonary Disease, Chronic Obstructive, Asthma | Phase 4 | Completed | General Hospital of Kavala | 101 | 2012-05-01 | 2016-10-04 |
| Bupropion for Smoking Cessation During Pregnancy Bupropion SR, Smoking Cessation Counseling, Placebo - Pregnancy Related, Tobacco Use Disorder | Phase 4 | Completed | The University of Texas Medical Branch, Galveston | 65 | 2011-07-01 | 2019-06-07 |
| Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient Web-based smoking cessation program - Cigarette Smoking, Home Access to Internet and Email | Phase 4 | Completed | University of Alabama at Birmingham | 1548 | 2011-07-01 | 2015-06-19 |
| Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole Behavioral Intervention - Substance Abuse, Substance Dependence | Phase 4 | Withdrawn | Northwell Health | 2011-06-01 | 2018-03-19 | |
| Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine Behavioral Intervention - Cannabis Dependence | Phase 4 | Completed | Northwell Health | 124 | 2010-10-22 | 2018-04-17 |
| Dental Caries Management by Risk Assessment: Identification and Treatment of Risk Factors Among (IDF) Personnel behavioral intervention - Dental Caries | Phase 4 | Unknown | Medical Corps, Israel Defense Force | 400 | 2010-06-01 | 2011-06-29 |
| Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia Nicotine Nasal Spray, Behavioral counseling - Smoking Cessation, Schizophrenia | Phase 4 | Completed | Rutgers, The State University of New Jersey | 66 | 2009-08-01 | 2014-09-08 |
| Smoking Study With Behavioral Therapy for Hypertensive Patients Varenicline, behavioral therapy - Cigarette Smoking, Hypertension | Phase 4 | Completed | UConn Health | 203 | 2009-04-01 | 2017-04-10 |
| Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) Luvox CR, Behavioral Therapy - Obsessive Compulsive Disorder | Phase 4 | Unknown | Rogers Center for Research & Training, Inc. | 50 | 2008-09-01 | 2008-09-04 |
| Cognitive-Behavior Therapy for Insomnia Cognitive-Behavior Therapy, Behavior Therapy, Cognitive Therapy - Chronic Insomnia | Phase 4 | Completed | Laval University | 186 | 2008-04-01 | 2013-07-02 |
| Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons Xenical + behavioral intervention, Behavioral intervention + placebo - Obesity, Binge Eating | Phase 4 | Completed | Yale University | 79 | 2007-08-01 | 2020-04-02 |
Showing 20 of 25. Sign in to see all of them.
Obesity (5) · Smoking Cessation (5) · Tobacco Use Disorder (3) · Appetitive Behavior (2) · Body Weight (2) · Body Weight Changes (2) · Cigarette Smoking (2) · Dental Caries (2) · Obsessive-Compulsive Disorder (2) · Overweight (2) · Parasomnias (2) · Substance-Related Disorders (2) · Weight Loss (2) · Anorexia (1) · Arthritis (1)
Northwell Health (2) · University of Pennsylvania (2) · American University of Beirut Medical Center (1) · Ankara Training and Research Hospital (1) · Dow University of Health Sciences (1) · Eva Szigethy (1) · General Hospital of Kavala (1) · Laval University (1) · Medical Corps, Israel Defense Force (1) · Nova Scotia Health Authority (1) · Novartis (1) · Ohio University (1) · Rogers Center for Research & Training, Inc. (1) · Rutgers, The State University of New Jersey (1) · State University of New York at Buffalo (1)
United States (18) · Canada (2) · Brazil (1) · Israel (1) · Lebanon (1) · Pakistan (1) · Turkey (Türkiye) (1)
Ahmet M Hascicek, M.D. (1) · Alpana P Shukla, MD (1) · Carlos M Grilo, PhD (1) · Charles M. Morin, PhD (1) · Cheryl Onken, MD, MPH (1) · Cristina B Silva, Psychologist (1) · Daniel A Waschbusch (1) · Dr Saba Arshad (1) · Eva Szigethy, MD, PhD (1) · Gary DV Hankins, MD (1) · James G Waxmonsky (1) · Jena S Tronieri, PhD (1) · Jill M Williams, MD (1) · John H Greist, MD (1) · Kathleen F Harrington, PhD, MPH (1)
PMID 19578654, PMID 20673557, PMID 20880898, PMID 21907540, PMID 22841131, PMID 22852802, PMID 23376451, PMID 23881652, PMID 23948637, PMID 26336372, PMID 26763501, PMID 26963600, PMID 27647062, PMID 27890648, PMID 28888814, PMID 29265834, PMID 31687769, PMID 34582624, PMID 36821333, PMID 37811598, PMID 38655793, PMID 40055520, PMID 42323166
R01DA008075 (1), R01DA024640 (1), R01DA024667 (1), R01DA030998 (1)